摘要
目的:探讨通过小干扰RNA(small interfering RNA, siRNA)技术敲减NOB1基因表达对人结肠癌SW480细胞活力、药物敏感性、凋亡、细胞周期及侵袭和迁移能力的影响。方法:利用脂质体Lipofectamine 3000将NOB1 siRNA转染至SW480细胞,采用real-time PCR和Western blot检测转染后SW480细胞中NOB1 mRNA和蛋白表达的变化;采用MTT法检测敲减NOB1基因表达后SW480细胞活力及其对不同化疗药物(顺铂、5-氟尿嘧啶、奥沙利铂和卡培他滨)敏感性的变化;流式细胞术检测敲减NOB1基因表达对SW480细胞凋亡和周期的影响;Transwell方法检测敲减NOB1基因表达对结肠癌SW480细胞侵袭和迁移能力的影响。结果:转染NOB1 siRNA后,SW480细胞中NOB1的mRNA和蛋白表达水平明显降低(P<0.05);与对照组和阴性对照siRNA组相比,NOB1 siRNA转染组的SW480细胞在24～72 h的细胞活力显著降低,顺铂、5-氟尿嘧啶、奥沙利铂和卡培他滨对该细胞的半数抑制浓度均显著降低,细胞凋亡率显著增加,细胞周期受到阻滞,细胞侵袭和迁移能力显著降低(P<0.05)。结论:NOB1 siRNA转染能够抑制结肠癌SW480细胞活力及侵袭和转移能力,并增强细胞对药物的敏感性,促进细胞凋亡。NOB1能够成为结肠癌诊断和治疗的新靶点。
AIM: To investigate the effect of NOB1 gene expression knock-down by transfection of small interfering RNA(siRNA) on the viability, drug sensitivity, apoptosis, cell cycle distribution, and invasion and migration abilities of human colon cancer SW480 cells. METHODS: NOB1 siRNA was transfected into SW480 cells using Lipofectamine 3000. The mRNA and protein levels of NOB1 in the SW480 cells were determined by real-time PCR and Western blot. The cell viability and sensitivity to different chemotherapeutic drugs(cisplatin, 5-fluorouracil, oxaliplatin and capecitabine) were detected by MTT assay after knock-down of NOB1 gene expression in the SW480 cells. The apoptosis and cell cycle distribution of SW480 cells were analyzed by flow cytometry. The invasion and migration abilities of SW480 cells were detected by Transwell assay. RESULTS: After transfection with NOB1 siRNA, the mRNA and protein levels of NOB1 in the SW480 cells were significantly decreased(P<0.05). Compared with control group and control siRNA group, the viability of SW480 cells in NOB1 siRNA group was significantly decreased at 24～72 h. The half maximal inhibitory concentrations of the chemotherapy drugs cisplatin, 5-fluorouracil, oxaliplatin and capecitabine were significantly decreased. The apoptotic rate was significantly increased and the cell cycle were blocked. The cell invasion and migration abilities were significantly reduced(P<0.05). CONCLUSION: Knock-down of NOB1 gene expression inhibits the viability and invasion and migration abilities of colon cancer SW480 cells, and promotes drug sensitivity and apoptosis. NOB1 may be a new target for diagnosis and treatment of colon cancer.
引文
[1] 李逦, 王纯, 卢宏达. 马钱子碱通过抑制IL-6/STAT3信号通路诱导结肠癌SW480细胞凋亡[J]. 中国病理生理杂志, 2016, 32(6):998-1003.
[2] 郑海伦, 赵睿, 李大鹏, 等. miR-625-3p在结肠癌组织和细胞中的表达[J]. 中国病理生理杂志, 2016, 32(8):1376-1382.
[3] Liu K, Gu MM, Chen HL, et al. NOB1 in non-small-cell lung cancer: expression profile and clinical significance[J]. Pathol Oncol Res, 2013, 20(2):461-466.
[4] 张媛媛, 宋育林. NOB1在胃癌组织中的表达及临床意义[J]. 安徽医药, 2013, 17(10):1707-1710.
[5] 吴东平, 贺孝文. 结直肠癌中NOB1基因的表达及意义[J]. 南方医科大学学报, 2012, 32(3):420-422.
[6] Misale S, Di Nicolantonio F, Sartore-Bianchi A, et al. Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution[J]. Cancer Discov, 2014, 4(11):1269-1280.
[7] 武月, 殷红专, 闫兆鹏, 等. NOB1在结直肠癌中的表达及其临床意义[J]. 现代肿瘤医学, 2013, 21(9):2044-2047.
[8] Kronborg O. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths[J]. N Engl J Med, 2012, 366(6):687-696.
[9] Lin Y, Peng S, Yu H, et al. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells.[J]. Med Oncol, 2011, 29(1):311-317.
[10] Liu K, Gu MM, Chen HL, et al. NOB1 in non-small-cell lung cancer: expression profile and clinical significance[J]. Pathol Oncol Res, 2013, 20(2):461-466.
[11] Lin Y, Xu T, Teng H, et al. Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells[J]. Int J Clin Exp Pathol, 2014, 8(9):10061-10071.
[12] 任建松, 石菊芳, 张洪召, 等. 2012-2013年中国城市人群大肠癌筛查结果初步分析[J]. 中华预防医学杂志, 2015,49(5):441-443.
[13] Dolfi SC, J?ger AV, Medina DJ, et al. Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs[J]. Cancer Lett, 2014, 350(1-2):52-60.
[14] Akao Y, Noguchi S, Iio A, et al. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells[J]. Cancer Lett, 2011, 300(2):197-204.
[15] Chen B, Liu J, Wu D, et al. Gene silencing of NOB1 by lentivirus suppresses growth and migration of human osteosarcoma cells[J]. Mol Med Rep, 2014, 9(6):2173-2179.
[16] Yin J, Wang J, Jiang Y, et al. Downregulation of NOB1 inhibits proliferation and promotes apoptosis in human oral squamous cell carcinoma[J]. Oncol Reports, 2015, 34(6):3077-3087.
[17] Tsuboy MS, Marcarini JC, de Souza AO, et al. Genistein at maximal physiologic serum levels induces G0/G1 arrest in MCF-7 and HB4a cells, but not apoptosis[J]. J Med Food, 2014, 17(2):218-225.
[18] Meng W, Wang PS, Liu J, et al. Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo[J]. Oncol Rep, 2014, 32(6):2411-2420.
[19] Schimanski CC, Frerichs K, Rahman F, et al. High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells[J]. World J Gastroenterol, 2015, 15(17):2089-2096.
